American Association for Cancer Research

Chromatin and Epigenetics in Cancer

Chromatin and Epigenetics in Cancer 2013Chromatin and Epigenetics in Cancer
June 19-22, 2013
Loews Atlanta Hotel
Atlanta, GA

Charles W.M. Roberts, Dana-Farber Cancer Institute, Boston, MA
Suzanne J. Baker, St. Jude Children's Research Hospital, Memphis, TN
Gerald R. Crabtree, Stanford University, Stanford, CA

Recent cancer genome sequencing efforts have revealed that genes involved in chromatin remodeling and epigenetic regulation are frequently and specifically mutated in a wide variety of cancers. While known to serve roles in the control of gene expression and development, these largely unanticipated mutation findings have illuminated newly recognized mechanisms central to the genesis of cancer. Gaining insight into these mechanisms will offer the potential to reveal novel approaches and targets for effective therapeutic intervention. The focus of this Special Conference was to bring together basic and translational scientists to discuss both their latest findings in the field of chromatin and epigenetic regulation, and how these findings can be used for the development of new therapeutic options for cancer treatment.

* Adobe Acrobat Reader required

Please visit the AACR Meetings & Workshops Calendar for a complete list of upcoming programs.

Lead Supporters:

Celgene           Genentech

Major Supporter:

Bristol-Myers Squibb


Amgen, Inc.         Zymo Research